Hippocratic AI Secures $141 Million in Series B Funding to Revolutionize Healthcare AI

Hippocratic AI, a pioneering company on a mission to revolutionize healthcare through artificial intelligence, has successfully secured $141 million in its latest funding round. With a focused vision to create the first safety-oriented Large Language Model (LLM) specifically tailored for the healthcare sector, Hippocratic AI aims to enhance healthcare accessibility and significantly improve health outcomes across the globe. Founded by a team of esteemed professionals, including CEO Munjal Shah, alongside physicians and researchers from prestigious institutions such as El Camino Health, Johns Hopkins, and Stanford, the company is at the forefront of integrating advanced AI technology into healthcare. This impressive funding round brings the total investment in Hippocratic AI to $137 million, with support from high-caliber investors such as General Catalyst, Andreessen Horowitz, and Nvidia Venture Capital, among others. The funds will be strategically allocated to further develop and refine their LLM, enabling it to assist healthcare professionals in delivering better patient care and ensuring that medical knowledge is more accessible to everyone. This critical investment not only reflects investor confidence in Hippocratic AI’s unique approach but also highlights the growing recognition of AI’s potential to address some of the most pressing challenges in healthcare. By harnessing the power of artificial intelligence, Hippocratic AI is poised to make a lasting global impact on health, and we look forward to seeing their innovative solutions come to life. For more details on their groundbreaking work, visit www.HippocraticAI.com.